Finally, for the determination of antibiotic susceptibility and MDR patterns of MRSA isolates, the Kirby-Bauer procedure was done according to CLSI recommendations as above mentioned for the following antibiotics: clindamycin (CD; 2 μg), trimethoprim-sulfamethoxazole (TS; 1.25 μg), gentamicin (GM; 10 μg), erythromycin (E; 15 μg), and linezolid (LZD; 30 μg) for S. aureus, as well as nalidixic acid (NA; 30 μg), colistin (CT; 10 μg), ampicillin (AMP; 10 μg), piperacillin (PRL; 100 μg), imipenem (IMP; 10 μg), cefepime (CPE; 30 μg), and chloramphenicol (C; 30 μg) for P. aeruginosa (Wayne, 2010 ). S. aureus ATCC 25923 was applied as the quality control. Finally, by observing at least one or more antibiotic resistances for three or more classes of antibiotics, MDR in selected MRSA and P. aeruginosa isolates was characterized (Mirzaei et al., 2022a (link)).
Free full text: Click here